Who is sponsoring NCT04006197?

NCT04006197 is sponsored by Assiut University.

What drugs are being tested in NCT04006197?

Interventions in NCT04006197: laryngostroboscopy and histoh-pathology.

What condition does NCT04006197 study?

NCT04006197 studies Vocal Cord Neoplasm.

Is NCT04006197 still recruiting?

NCT04006197 is currently completed. Last updated 6 January 2026.

Last reviewed 2026-01-06 · How we verify

NCT04006197

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vocal Folds Irregular Mucosal Changes: A Clinical, Pathological and Genetic Study

Completed Last updated 6 January 2026

What this trial tests

trial testing laryngostroboscopy and histoh-pathology in Vocal Cord Neoplasm in 100 participants. Completed in 1 August 2023.

Timeline

1 March 2021

Primary endpoint
1 August 2023

1 August 2023

Quick facts

Lead sponsor	Assiut University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 March 2021
Primary completion	1 August 2023
Estimated completion	1 August 2023
Sites	1 location across Egypt

Drugs / interventions tested

laryngostroboscopy and histoh-pathology

Conditions studied

Vocal Cord Neoplasm — all drugs for Vocal Cord Neoplasm →

Sponsor

Assiut University

Who can join

Adults 18 to 70, male only, with Vocal Cord Neoplasm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

simple combination of functional investigation, in form of laryngostroboscopy, together with conventional histopathological examination, provides a highly sensitive method in differential diagnosis of undiagnosed vocal folds irregularites

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04006197 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 6 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04006197.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing